TCL Archive Administration Asking $233 Million Less For NCI In FY ’88 Than Congress Is Appropriating For ‘87 October 10, 1986
TCL Archive Abraxane-Gemcitabine Combination Extends Overall Survival in Phase III Trial January 31, 2014
TCL Archive Two former Bristol-Myers Squibb executives were indicted as the company agreed to pay $300 million to investors. June 17, 2005